Various enzyme activities in muscle and other organs of dystrophic mice.
- 1 January 1981
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 67 (1) , 51-59
- https://doi.org/10.1172/jci110032
Abstract
To elucidate the metabolic abnormality of musclar dystrophy, 27 kinds of enzyme activity in various organs of control and dystrophic mice were examined. The organs examined included muscle, bone, heart, testis, uterus, spleen, thymus, submaxillary gland, stomach, pancreas, liver, kidney, brain, and lung. The activities of 14 different aminopeptidases, 5 endopeptidases, 4 glycosidases, phosphatase, esterase, and ribonuclease were measured. Most of the enzyme activities were significantly elevated in muscles and bones of dystrophic mice. These organs were similar in their patterns of enzyme abnormality. Among the 14 kinds of aminopeptidase activity studied, the degree of increased activity was greater for the aminopeptidases (AP):Ala-AP, Leu-AP, Met-AP, Phe-AP, Trp-AP, Gly-Pro-Leu-AP. In addition to aminopeptidases, there were significant increases in activities of chymotrypsinlike enzyme, cathepsin C, cathepsin D, several glycosidases and neutral ribonuclease in the muscles of dystrophic mice. Similarly increased enzyme activity was also observed in organs other than muscle and bone. Furthermore, protein content in most organs was higher in dystrophic mice than in those of control mice. These abnormalities were seen in both males and females. The present results suggest that there are extensive abnormalities in the protein metabolism in dystrophic mice. It seems therefore that the therapeutic approach to muscular dystrophy should be studies not only from the well-known abnormality of intramuscular endopeptidases, but from other aspects as well.This publication has 17 references indexed in Scilit:
- Muscular Dystrophy: Inhibition of Degeneration in Vivo with Protease InhibitorsScience, 1978
- Leupeptin, a Protease Inhibitor, Decreases Protein Degradation in Normal and Diseased MusclesScience, 1978
- Serine Protease in Mice with Hereditary Muscular Dystrophy1The Journal of Biochemistry, 1978
- Release of a plasma membrane-bound triaminopeptidase activity from mammalian cells by thermolysinBiochemical and Biophysical Research Communications, 1978
- The inhibition by pepstatin of cathepsin D and autolysis of dystrophic muscleLife Sciences, 1976
- Aminopeptidase activities on the surface of mammalian cellsBiochimica et Biophysica Acta (BBA) - Enzymology, 1976
- Delayed degeneration of dystrophic and normal muscle cell cultures treated with pepstatin, leupeptin, and antipainExperimental Neurology, 1976
- Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes.The Journal of Antibiotics, 1976
- Change of enzyme activities during the early stage of influenza virus infectionBiochemical and Biophysical Research Communications, 1974
- EFFECT OF PEPSTATIN ON ACID PROTEASESThe Journal of Antibiotics, 1971